Synergy CHC Corp. defaults on $17.6M term loan as forbearance ends
SNYR is trading near its 52-week low of $0.161 (2.4% above the low).
Summary
Synergy CHC Corp. received a default notice after failing to make an interest payment on its $17.6 million term loan. The forbearance period has ended, and the lender can now accelerate the debt.
Key Events · Legal and Risk Events · SNYR
-
Default on $17.6M Term Loan
ACP Agency, LLC issued a default notice after Synergy CHC Corp. failed to make the interest payment due August 3, 2026, with the cure period expiring August 6.
-
Forbearance Terminated
The forbearance agreement dated May 28, 2026, was terminated as a result of the default, and a forbearance fee of $404,173.06 is now due and payable.
-
Lender Rights Accelerated
ACP reserved all rights under the Credit Agreement, including charging post-default interest, accelerating the $17.6 million principal, and exercising other remedies.
-
Precarious Financial Position
The default follows the recent loss of Costco as a customer (representing a significant portion of revenue) and a Nasdaq delisting notice, with the stock trading near its 52-week low of $0.1611.
Analysis · SNYR · Life Sciences
A missed interest payment on its $17.6 million term loan has triggered a default notice from agent ACP, putting Synergy CHC Corp. in a precarious position. The forbearance agreement that had been keeping lenders at bay is now terminated, and a $404,173 forbearance fee is immediately due. With the stock trading near all-time lows and the company already reeling from the loss of its largest customer, this default puts the entire capital structure at risk — acceleration of the full $17.6 million could force a restructuring or bankruptcy.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 46.1% of the 284 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SNYR was trading at $0.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.5M. The 52-week trading range was $0.16 to $3.99. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.